Literature DB >> 2554311

Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.

T D Bartley1, D W Whiteley, V L Mar, D L Burns, W N Burnette.   

Abstract

The cytotoxicity of pertussis toxin, a multisubunit exotoxin produced by Bordetella pertussis, is believed to be due to the ADP-ribosyltransferase activity of the S1 subunit. We have previously described the recombinant expression of each of the five individual pertussis toxin subunits in Escherichia coli and the production of an enzymatically deficient form of the S1 subunit by site-directed mutagenesis. We now report the in vitro assembly of holotoxin from native pertussis toxin B oligomer and recombinant S1 subunits, the latter purified and refolded from insoluble inclusion bodies. Holotoxin assembled with recombinant S1 of authentic amino acid sequence was indistinguishable from native pertussis toxin in its electrophoretic migration and ability to elicit a cytopathic response in cultured Chinese hamster ovary cells; in contrast, holotoxin assembled with the genetically deactivated analog of recombinant S1 displayed greatly diminished cytopathicity. These results verify that the in vitro cytopathic effects of pertussis toxin are the result of the enzymatic activity of the S1 subunit and illustrate the potential for constructing complex quaternary protein structures in vitro from insoluble, unfolded polypeptides derived from expression in recombinant systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554311      PMCID: PMC298279          DOI: 10.1073/pnas.86.21.8353

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

2.  Immune response to the B oligomer of pertussis toxin.

Authors:  J L Arciniega; D L Burns; E Garcia-Ortigoza; C R Manclark
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.

Authors:  M Tamura; K Nogimori; S Murai; M Yajima; K Ito; T Katada; M Ui; S Ishii
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

7.  Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.

Authors:  L A Ashworth; A Robinson; L I Irons; C P Morgan; D Isaacs
Journal:  Lancet       Date:  1983-10-15       Impact factor: 79.321

8.  Pertussis immunisation and serious acute neurological illness in children.

Authors:  D L Miller; E M Ross; R Alderslade; M H Bellman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

9.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

View more
  11 in total

1.  Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.

Authors:  R Latif; N Kerlero de Rosbo; T Amarant; R Rappuoli; G Sappler; A Ben-Nun
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli.

Authors:  W N Burnette; J L Arciniega; V L Mar; D L Burns
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Pertussis toxin has eukaryotic-like carbohydrate recognition domains.

Authors:  K Saukkonen; W N Burnette; V L Mar; H R Masure; E I Tuomanen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

5.  Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells.

Authors:  M J Walker; J Wehland; K N Timmis; B Raupach; M A Schmidt
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.

Authors:  W N Burnette; V L Mar; B W Platler; J D Schlotterbeck; M D McGinley; K S Stoney; M F Rohde; H R Kaslow
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin.

Authors:  J L Arciniega; R D Shahin; W N Burnette; T D Bartley; D W Whiteley; V L Mar; D L Burns
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.

Authors:  M J Walker; M Rohde; J Wehland; K N Timmis
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin.

Authors:  K M Krueger; J T Barbieri
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 10.  Progress with a recombinant whooping cough vaccine: a review.

Authors:  W N Burnette; V L Mar; D W Whiteley; T D Bartley
Journal:  J R Soc Med       Date:  1992-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.